BioWorld

Feb. 16, 2007

Biogen Idec Increases Profits But Misses 4Q EPS Estimates

Biogen Idec Inc. turned in adjusted earnings per share of 53 cents for the quarter ended Dec. 31, two pennies lower than consensus estimates on revenue that also came in weaker than expected. (BioWorld Today) Read More

NovaBay Seeks Dual Listing, Aims For $23M In IPO Filing

Developmental Master Molecule Adds Palate Formation To Tasks

Cepheid Buys Diagnostics Firm, Boosts Portfolio of Assay Tools

Holiday Notice

Other News To Note

Clinic Roundup

Today's news in brief

BioWorld

BioWorld briefs for July 3, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for July 3, 2025.

AI-generated illustration of CAR T cells

Researchers arm CAR T cells to fight solid tumors

BioWorld

Aussie researchers have used CRISPR gene editing tools to “armor” chimeric antigen receptor (CAR) T cells to activate additional cancer-fighting proteins at the...

Bioversys, Shionogi in CHF529M lung infection collaboration

BioWorld Science

Antibiotics specialist Bioversys AG has sealed a potential CHF529 million (US$667.5 million) deal with Shionogi Co. Ltd., in which they will work together on...

Medtronic receives CE mark for its Vitalflow ECMO system

BioWorld MedTech

Medtronic plc received a CE mark for its Vitalflow extracorporeal membrane oxygenation (ECMO) system, which provides temporary support for the heart and lungs in...